Compare VIR & CNNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VIR | CNNE |
|---|---|---|
| Founded | 2016 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 773.5M | 871.1M |
| IPO Year | 2019 | N/A |
| Metric | VIR | CNNE |
|---|---|---|
| Price | $5.84 | $16.07 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 4 |
| Target Price | ★ $25.73 | $22.25 |
| AVG Volume (30 Days) | ★ 2.0M | 737.8K |
| Earning Date | 11-05-2025 | 11-10-2025 |
| Dividend Yield | N/A | ★ 3.75% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $16,860,000.00 | ★ $430,200,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $48.05 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.16 | $15.05 |
| 52 Week High | $14.45 | $21.96 |
| Indicator | VIR | CNNE |
|---|---|---|
| Relative Strength Index (RSI) | 43.19 | 41.89 |
| Support Level | $6.49 | $15.92 |
| Resistance Level | $6.75 | $17.24 |
| Average True Range (ATR) | 0.47 | 0.40 |
| MACD | -0.09 | -0.00 |
| Stochastic Oscillator | 22.98 | 6.77 |
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
Cannae Holdings Inc is a holding company that manages and operates a group of companies and investments. The company's reportable segments are Restaurant Group, Dun & Bradstreet, Alight, BKFC, Corporate and Other. Majority of the company's revenue is generated from its Restaurant Group segment which represents the operations of O'Charley's and Ninety Nine Restaurants.